Literature DB >> 6761032

Clinical pharmacokinetics of oral activated charcoal in acute intoxications.

P J Neuvonen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6761032     DOI: 10.2165/00003088-198207060-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  72 in total

1.  THE BLACK BOTTLE. A CONSIDERATION OF THE ROLE OF CHARCOAL IN THE TREATMENT OF POISONING IN CHILDREN.

Authors:  L E HOLT; P H HOLZ
Journal:  J Pediatr       Date:  1963-08       Impact factor: 4.406

2.  Experimental studies on the pharmacology of activated charcoal; adsorption power of charcoal in aqueous solutions.

Authors:  A H ANDERSEN
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1946

3.  Treatment of digoxin intoxication.

Authors:  G Härtel; V Manninen; P Reissell
Journal:  Lancet       Date:  1973-07-21       Impact factor: 79.321

4.  Effect of oral charcoal on plasma levels of intravenous methyl proscillaridin.

Authors:  G G Belz; H Bader
Journal:  Klin Wochenschr       Date:  1974-12-01

5.  Activated charcoal preparations--relative antidotal efficacy.

Authors:  A L Picchioni; L Chin; H E Laird
Journal:  Clin Toxicol       Date:  1974       Impact factor: 4.467

6.  Optimal antidotal dose of activated charcoal.

Authors:  L Chin; A L Picchioni; W M Bourn; H E Laird
Journal:  Toxicol Appl Pharmacol       Date:  1973-09       Impact factor: 4.219

7.  Oral activated charcoal and dapsone elimination.

Authors:  P J Neuvonen; E Elonen; M J Mattila
Journal:  Clin Pharmacol Ther       Date:  1980-06       Impact factor: 6.875

8.  Effect of activated charcoal on absorption of nortriptyline.

Authors:  P Crome; S Dawling; R A Braithwaite; J Masters; R Walkey
Journal:  Lancet       Date:  1977-12-10       Impact factor: 79.321

9.  Theophylline absorption by effervescent activated charcoal (Medicoal).

Authors:  M Helliwell; D Berry
Journal:  J Int Med Res       Date:  1981       Impact factor: 1.671

10.  Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication.

Authors:  J H Caldwell; N J Greenberger
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

View more
  28 in total

Review 1.  Activated charcoal in the treatment of drug overdose. An update.

Authors:  W Palatnick; M Tenenbein
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

2.  Comparative antidotal efficacy of activated charcoal tablets, capsules and suspension in healthy volunteers.

Authors:  H P Remmert; M Olling; W Slob; W F van der Giesen; A van Dijk; A G Rauws
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide.

Authors:  P J Neuvonen; K Kivistö; E L Hirvisalo
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

Review 4.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

5.  Hypernatremia associated with cathartics in overdose management.

Authors:  J W Caldwell; A J Nava; D D de Haas
Journal:  West J Med       Date:  1987-11

6.  Role of repeated oral doses of activated charcoal in clinical toxicology.

Authors:  S M Pond
Journal:  Med Toxicol       Date:  1986 Jan-Feb

7.  Treatment of quinine overdosage with repeated oral charcoal.

Authors:  L F Prescott; A R Hamilton; R Heyworth
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

8.  Amatoxin poisoning in northern California, 1982-1983.

Authors:  S M Pond; K R Olson; O F Woo; J D Osterloh; R E Ward; D A Kaufman; R R Moody
Journal:  West J Med       Date:  1986-08

Review 9.  Activated charcoal--past, present and future.

Authors:  R W Derlet; T E Albertson
Journal:  West J Med       Date:  1986-10

Review 10.  A reassessment of the treatment of salicylate poisoning.

Authors:  L Notarianni
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.